Histopathological evaluation of chromoblastomycosis: A literature review

Authors

DOI:

https://doi.org/10.33448/rsd-v10i6.16027

Keywords:

Fungus; Chromoblastomycosis; Diagnosis; Histology; Histologic technique.

Abstract

Chromoblastomycosis (CBM) is a cutaneous or subcutaneous mycoses. The trauma occurs when the fungus is installed and is more prevalent in individuals living in tropical and subtropical regions, with earliest descriptions dating back to 1920. The diagnosis of CBM is based on the incidence of cases in the endemic areas and is commonly reached through microbiological analyses to identify the etiologic agent in clinical samples. The process for the analysis of the collected samples allows one to visualise the muriform cells, which are brown, rounded structures having crossed chambers and that can be commonly called sclerotic bodies, characterising the positive diagnosis. The objective of this review was to verify the connection of the histopathological techniques to the diagnosis of CBM.

References

Abdullah, E., Idris, A., & Saparon., A. (2017). Papr reduction using scs-slm technique in stfbc mimo-ofdm. ARPN Journal of Engineering and Applied Sciences 12(10):3218–3221.

Al-Doory, Y. (1983). Chromomycosis. In: Di Salvo, A. F. Occupational mycoses. Philadelphia: Lea & Febiger, 95-121.

Ameen, M. (2009). Chromoblastomycosis: clinical presentation and management. Clin Exp Dermatol; 34:849 – 854. https://doi.org/10.1111/j.1365-2230.2009.03415.x.

Azevedo, C. M. P. S., Marques, S. G., & Santos, D. W. C. L. (2015). Squamous cell carcinoma derived from chronic chromoblastomycosis in Brazil. Clinical Infectious Diseases, 60(10):1500–1504. https://doi.org/10.1093/cid/civ104.

Badali, H., Bonifaz, A., & Barrn-Tapia, T. (2010). Rhinocladiella aquaspersa, proven agent of verrucous skin infection and a novel type of chromoblastomycosis. Medical Mycology, 48(5):696–703. https://doi/org/10.3109/13693780903471073.

Badali, H., et al. (2008). Biodiversity of the genus Cladophialophora. Stud Mycol, 61(1):175-91. https://doi.org/10.3114/sim.2008.61.18.

Bhattacharjee, R., Narang, T., & Chatterjee, D. (2019). Cutaneous Chromoblastomycosis: A Prototypal Case. Journal of cutaneous medicine and surgery, 23(1):98-98. https://doi.org/10.1177/1203475418789029.

Bonifaz, A., Carrasco-Gerard, E., & Saul, A. (2010). Chromoblastomycosis: clinical and mycologic experience of 51 cases. Mycoses, 44:1-7. https://doi.org/ 10.1046/j.1439-0507.2001.00613. x.

Burlingame, E. A., et al. (2018). SHIFT: speedy histopathological-to-immunofluorescent translation of whole slide images using conditional generative adversarial networks. In: Medical Imaging 2018: Digital Pathology. International Society for Optics and Photonics, 1058105. https://doi.org/10.1117/12.2293249.

Camara-Lemarroy, C. R., Soto-Garcia, A. J., & Preciado-Yepez, C. I. (2013). Case of chromoblastomycosis with pulmonary involvement. Journal of Dermatology, 2013; 40(9):746–748. https://doi.org/10.1111/1346-8138.12216.

Chavan, S. S., Kulkarni., M. H., & Makannavar, J. H. (2010). “Unstained” and “de stained” sections in the diagnosis of chromoblastomycosis: a clinico-pathological study. Indian journal of pathology & microbiology, 53(4):666–671. https://doi.org/10.4103/0377-4929.72021.

Da Silva., et al. (2008). Development of natural culture media for rapid induction of Fonsecaea pedrosoi sclerotic cells in vitro. J Clin Microbiol, 46(11):3839-3841. https://doi.org/10.1128/JCM.00482-08.

De Azevedo., C. M., Gomes, R. R., & Vicente, V. A. (2015). Fonsecaea pugnacius, a novel agent of disseminated chromoblastomycosis. Journal of Clinical Microbiology, 53(8):2674–2685. https://doi.org/10.1128/JCM.00637-15.

De Hoog, G. S., et al. (2000). Black fungi: clinical and pathogenic approaches. Med Mycol, ;38:243-50.

Elfer, K. N., et al. (2016). DRAQ5 and eosin (‘D&E’) as an analog to hematoxylin and eosin for rapid fluorescence histology of fresh tissues. PLoS One, 11(10): e0165530. https://doi.org/10.1371/journal.pone.0165530.

Freudiger, C. W., et al. (2012). Multicolored stain-free histopathology with coherent Raman imaging. Laboratory investigation, 92(10):1492. https://doi.org/10.1038/labinvest.2012.109.

Gajjar, D. U., Pal, A. K., & Santos, J. M. (2011). Severe pigmented keratitis caused by Cladorrhinum bulbillosum. Indian J Med Microbiol, 29(4):434–437. https://doi.org/10.4103/0255-0857.90191. PMID: 22120812.

Galvão, T. F., & Pereira, M. G. (2014). Revisões sistemáticas da literatura: passos para sua elaboração. Epidemiologia e Serviços de Saúde, 23(1):183–184. https://doi.org/10.5123/S1679-49742014000100018.

Giacomelli, M. G., et al. (2016).Virtual hematoxylin and eosin transillumination microscopy using epi-fluorescence imaging. PLoS One, 11(8):e0159337. https://doi.org/10.1371/journal.pone.0159337.

Hay, R. (2019). The diagnosis of fungal neglected tropical diseases (fungal NTDs) and the role of investigation and laboratory tests: An expert consensus report. Tropical medicine and infectious disease, 4(4):122. https://doi.org/10.3390/tropicalmed4040122.

He, L., et al. (2018). Successful treatment of chromoblastomycosis of 10‐year duration due to Fonsecaea nubica. Mycoses, 61(4):231-236. https://doi.org/10.1111/myc.12732.

Jaleel, A., et al. (2017). Mycetoma‐like chromoblastomycosis: a diagnostic dilemma. International journal of dermatology, 56(5):563-566. https://doi.org/10.1111/ijd.13499.

Jamil, A., Lee, Y. Y., & Thevarajah, S. (2012). Invasive squamous cell carcinoma arising from chromoblastomycosis. Medical Mycology, 50(1):99–102. https://doi.org/10.3109/13693786.2011.571295.

Jayasree, P., et al. (2019). Dermoscopic features in nodular chromoblastomycosis. International journal of dermatology, 58(5):107-109. https://doi.org/10.1111/ijd.14344.

Kim, D. M., Hwang, S. M., & Suh, M. K. (2011). Chromoblastomycosis Caused by Fonsecaea pedrosoi. Annals of dermatology, 23(3):369–74. https://doi.org/10.5021/ad.2011.23.3.369

Lahiani, A. K., & Eldad, G. R. O. (2018). Enabling Histopathological Annotations on Immunofluorescent Images through Virtualization of Hematoxylin and Eosin. J Pathol Inform. https://doi.org/10.4103/jpi.jpi_61_17.

Le, Ta., et al. (2019). Case Report: A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi in Vietnam, Mycopathologia, 184(1):115–119. 10.1007/s11046-018-0284-3.

López-Martínez., & Méndez-Tovar, L. J. (2007). Chromoblastomycosis. Clin Dermatol, 25:188–94. https://doi.org/10.1128/CMR.00032-16.

Lyon, J. P., et al. (2011). Photodynamic Antifungal Therapy Against Chromoblastomycosis. Mycopathologia, 172( 4):293–297. https://doi.org/10.1007/s11046-011-9434-6.

Mcginnis, M. R. (1983). Chromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology. J Am Acad Dermatol,8:1-16. https://doi.org/10.1016/s0190-9622(83)70001-0.

Mendoza, L., Karuppayil, S. M., & Szaniszlo, P. J. (1993). Calcium regulates in vitro dimorphism in chromoblastomycotic fungi. Mycoses, 36(5-6):157-64. 10.1111/j.1439-0507.1993.tb00744.x.

Mittal, A., et al. (2014). Chromoblastomycosis from a non-endemic area and response to itraconazole. Indian journal of dermatology, 59(6):606. https://doi.org/10.4103/0019-5154.143537.

Moher, D., Liberati, A., & Tetzlaff, J. (2009). Guidelines and Guidance Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med, 6: e1000097. https://doi.org/10.1186/2046-4053-4-1.

Pradeepkumar, N. S., & Joseph, N. M. (2011). Chromoblastomycosis caused by Cladophialophora carrionii in a child from India. Journal of Infection in Developing Countries, 5 (7):556–560. https://doi.org/10.3855/jidc.1392.

Purim, K. S. M., Peretti., M. C., & Neto, J. F. (2017). Chromoblastomycosis: Tissue modifications during itraconazole treatment. Anais Brasileiros de Dermatologia 2017; 92(4):478–483. https://doi.org/10.1590/abd1806-4841.20175466.

Queiroz-Telles, F., et al. (2009). Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. Med Mycol, 47:3-15. https://doi.org/10.1080/13693780802538001.

Queiroz-Telles, F., & Santos, D. W. (2013). Challenges in the therapy of chromoblastomycosis. Mycopathologia, 175:477-88. https://doi.org/10.1007/s11046-013-9648-x.

Queiroz-Telles, F., et al. (2011). Mycoses of implantation in Latin America: an overview of epidemiology, clinical manifestations, diagnosis and treatment. Med Mycol, 49:225-36. https://doi.org/10.3109/13693786.2010.539631.

Stefanović, D. (2015). Use of eriochrome cyanine R for routine histology and histopathology: an improved dichromatic staining procedure. Biotechnic & Histochemistry, 90(6):470-474. https://doi.org/10.3109/10520295.2015.1058420.

Stefanović, D. S., & Marija, L. D. (2015). Use of eriochrome cyanine R in routine histology and histopathology: is it time to say goodbye to hematoxylin? Biotechnic & histochemistry, 90(6):461-469. https://doi.org/10.3109/10520295.2015.1057765.

Weedon, D., Deurse, M., & Allison, S. (2013). Chromoblastomycosis in Australia: An historical perspective. Pathology, 45(5):489–491. https://doi.org/10.1097/PAT.0b013e32836326a1.

Zhang, R., et al. (2019). A Case of Chromoblastomycosis Caused by Fonsecaea Pedrosoi and Investigation of the Pathogenic Fungi, Mycopathologia, 184(2):349-352. https://doi.org/10.1007/s11046-019-0319-4

Zhu, C. Y., Yang, Y. P., & Sheng, P. (2015). Cutaneous Chromoblastomycosis Caused by Veronaea botryosa in a Patient with Pemphigus Vulgaris and Review of Published Reports. Mycopathologia, 180(1–2):123–129. https://doi.org/10.1007/s11046-015-9887-0.

Downloads

Published

07/06/2021

How to Cite

AMARAL, M. C. do .; CARVALHO, A. dos S. .; ALVES, E. H. P. .; NASCIMENTO, H. M. S. .; RODRIGUES, A. A. .; CAETANO, V. da S. .; SILVA, B. C. .; FERNANDES, T. R. S.; FERNANDES, J. R. N. .; RÊGO, N. T. D. S. do .; PAIVA, A. F. de .; MEDEIROS, C. A. C. .; FREITAS, S. M. C. .; MACHADO, M. S. de M. .; VASCONCELOS, D. F. P. . Histopathological evaluation of chromoblastomycosis: A literature review . Research, Society and Development, [S. l.], v. 10, n. 6, p. e47410616027, 2021. DOI: 10.33448/rsd-v10i6.16027. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/16027. Acesso em: 4 nov. 2024.

Issue

Vol. 10 No. 6

Section

Health Sciences

License

Copyright (c) 2021 Mateus Cardoso do Amaral; André dos Santos Carvalho; Even Herlany Pereira Alves; Hélio Mateus Silva Nascimento; Ayane Araújo Rodrigues; Vinicius da Silva Caetano; Bruno Costa Silva; Thayaná Ribeiro Silva Fernandes; Jacks Renan Neves Fernandes; Nathalia Thamires Duarte Sousa do Rêgo; Arisvelton Fernandes de Paiva; Clarissy Andrade Costa Medeiros; Sijomara Maria Costa Freitas; Maria Sarah de Macedo Machado; Daniel Fernando Pereira Vasconcelos

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.